Table 1 Comparison of baseline data of patients with or without EV or EVH
Variable | n (%)/Mean ± SD | EV | p value | EVH | p value | ||
|---|---|---|---|---|---|---|---|
No (n = 35) | Yes (n = 50) | No (n = 43) | Yes (n = 42) | ||||
Median (IQR) | Median (IQR) | ||||||
Age/years | 53.82 ± 8.9 | 55.57 ± 9.4 | 52.60 ± 8.5 | = 0.133* | 55.30 ± 8.8 | 52.31 ± 8.9 | = 0.124* |
Sex | |||||||
Female | 30 (35.3%) | 13 (37.1%) | 17 (34%) | = 0.756** | 16 (37.2%) | 14 (33.3%) | = 0.709** |
Male | 55 (64.7%) | 22 (62.9%) | 33 (66%) | 27 (62.8%) | 28 (66.7%) | ||
EVs at CT | |||||||
Existence | 50 (58.8%) | 0 (0%) | 50 (100%) | < 0.001** | 19 (44.2%) | 31 (73.8%) | = 0.131** |
Size | |||||||
< 2 mm | 16 (32%) | 19 (54.3) | 16 (32) | = 0.112** | 20 (46.5%) | 2 (4.8%) | = 0.098*** |
2–4 mm | 11 (22%) | 9 (25.7) | 10 (20) | = 0.233** | 22 (51.2) | 18 (42.9) | = 0.832*** |
> 4 mm | 23 (46%) | 7 (20) | 24 (48) | = 0.098** | 1 (2.3) | 22 (52.4) | = 0.001*** |
Para-esophageal collateral | |||||||
Existence | 42 (49.4%) | 0 (0%) | 42 (84%) | < 0.001** | 4 (9.3%) | 38 (90.5%) | < 0.001** |
Size | 5.40 ± 1.4 | 0 (0) | 6 (2) | NA | 7.2 (4) | 6 (3) | = 0.468*** |
Short gastric collateral | |||||||
Existence | 51 (60%) | 16 (45.7%) | 35 (70%) | = 0.024** | 20 (46.5%) | 31 (73.8%) | = 0.010** |
Size | 3.51 ± 0.8 | 4 (3) | 3 (1.5) | = 0.457*** | 3.6 (3) | 3.2 (1) | = 0.946*** |
Peri-splenic collateral | |||||||
Existence | 19 (22.4%) | 13 (30.2%) | 6 (14.3%) | = 0.118** | 15 (24.2%) | 4 (17.4%) | = 0.504** |
Size | 4.12 ± 0.9 | 3 (1.9) | 3.2 (1.6) | = 0.101*** | 3.2 (2) | 3.3 (1) | = 0.984*** |
Lino-renal collateral | |||||||
Existence | 61 (71.8%) | 24 (68.6%) | 37 (74%) | = 0.584** | 29 (76.4%) | 32 (76.2%) | = 0.370** |
Size | 6.03 ± 1.7 | 7.5 (4) | 7 (2) | = 0.988*** | 7 (3) | 7 (2) | = 0.942*** |
Omental collateral | |||||||
Existence | 34 (40%) | 16 (37.2%) | 18 (42.9%) | = 0.595** | 24 (38.7%) | 10 (43.5%) | = 0.690** |
Size | 3.11 ± 0.9 | 4.4 (0.9) | 4.3 (1.5) | = 0.112*** | 4.8 (1) | 3.8 (1) | = 0.148*** |
Para-umbilical collateral | |||||||
Existence | 46 (54.1%) | 21 (60%) | 25 (50%) | = 0.363** | 24 (55.8%) | 22 (52.4%) | = 0.751** |
Size | 5.58 ± 1.3 | 3.5 (3) | 5 (3.5) | = 0.121*** | 3.6 (2) | 4.8 (3) | = 0.134*** |
IVC | |||||||
AP | 21.98 ± 4.1 | 20 (6) | 20 (5.5) | = 0.479*** | 20 (4) | 23 (5.5) | = 0.260*** |
Width | 28.80 ± 7.8 | 30 (10) | 30 (5) | = 0.923*** | 28 (10) | 30 (6) | = 0.681*** |
MCV | 3.72 ± 2.7 | 2 (1) | 4.7 (1) | < 0.001** | 3 (1) | 4 (2) | = 0.011** |
LGV | 2.10 ± 1.9 | 0.62 (0.3) | 0.66 (0.5) | = 0.389*** | 0.62 (0.8) | 0.66 (0.9) | = 0.356*** |
RPV | 2.75 ± 2.1 | 1.21 (0.5) | 1.33 (0.9) | = 0.158*** | 1.22 (1.7) | 1.31 (0.3) | = 0.568*** |
LPV | 3.06 ± 2.8 | 1.38 (1.4) | 1.31 (1.5) | = 0.211*** | 1.35 (1.6) | 1.30 (1.5) | = 0.274*** |
MPV | 16.71 ± 1.8 | 14.7 (0.2) | 15.82 (0.3) | = 0.133*** | 14.56 (0.2) | 15.75 (0.2) | < 0.121*** |
SPV | 3.04 ± 3.0 | 1.42 (1.3) | 1.46 (0.3) | = 0.785*** | 1.44 (1.2) | 1.45 (0.3) | = 0.775*** |
Child score category | |||||||
Child A | 21 (24.7%) | 18 (51.4%) | 3 (6%) | 21 (48.8%) | 0 (0%) | ||
Child B | 29 (34.1%) | 1 (2.9%) | 28 (56%) | 3 (7%) | 26 (61.9%) | ||
Child C | 35 (41.2%) | 19 (44.2%) | 16 (38.1%) | = 0.213** | 30 (48.4%) | 5 (21.6%) | < 0.001** |
IMV size | 4.26 ± 1.7 | 4 (2.5) | 4 (2.8) | = 0.791*** | 4 (2) | 4.3 (3) | = 0.149*** |
SMV Size | 12.57 ± 3.3 | 12 (6) | 11.5 (6) | = 0.530*** | 11 (6) | 12 (6) | = 0.603*** |
PUV size | 10.19 ± 2.6 | 10 (3.7) | 9 (2.8) | = 0.288*** | 10 (4) | 9 (3) | = 0.420*** |
Splenic size | 138.78 ± 43.7 | 150 (40) | 142.5 (55) | = 0.516*** | 145 (55) | 147.5 (46) | = 0.826*** |
Ascites (+) | 34 (40%) | 17 (48.6%) | 17 (34%) | = 0.177** | 17 (39.5%) | 17 (40.5%) | = 0.929** |
Gastric varicosities | |||||||
Existence | 34 (40%) | 2 (5.7%) | 32 (64%) | < 0.001** | 3 (7%) | 31 (73.8%) | < 0.001** |
Size | 2.22 ± 1.3 | 0.4 (0) | 2.3 (1.5) | = 0.004*** | 0.5 (0) | 2.5 (1) | < 0.001*** |
Coronary collateral (+) | 38 (44.7%) | 5 (14.3%) | 33 (66%) | < 0.001** | 5 (11.6%) | 33 (78.6%) | < 0.001** |